their executive departments are distinct, owing to the
subject matter they cover. Finally, a specific
emphasis was placed on all aspects of the business
continuity management model that link directly or
indirectly to the risk approach. The theoretical
background analysis was conducted to interpret the
approach and methodology used by a pharmaceutical
company during the COVID-19 pandemic to ensure
business continuity by adhering to quality
management and business continuity, risk
management standards, as well as its know-how and
structured approach to problem solving.
Additionally, the study's objective was to emphasize
the critical nature of harmonizing the requirements of
various management standards in order to make it
easier for firms to develop and operate an integrated
management system. In this regard, a future study
might focus on further developing the method of
harmonizing the various management standards, as
well as on the risk and operational impact of other
disorganizing occurrences. Finally, given the
pandemic's unique characteristics and the fact that
many of the measures taken to manage this health
crisis are heavily reliant on the human factor and
individual accountability, it is concluded that the
pharmaceutical company studied successfully
developed an effective action plan in order to
mitigate identified risks to acceptable levels,
maintain business continuity, and ensure the
product's quality.
References:
[1] Abou-El-Enein, M., Römhild, A., Kaiser, D.,
Beier, C., Bauer, G., Volk, H.-D., & Reinke, P.
(2013). Good Manufacturing Practices (GMP)
manufacturing of advanced therapy medicinal
products: a novel tailored model for optimizing
performance and estimating costs. Cytotherapy,
15(3), 362–383.
https://doi.org/10.1016/j.jcyt.2012.09.006
[2] Djalante, R., Shaw, R., & DeWit, A. (2020).
Building resilience against biological hazards
and pandemics: COVID-19 and its implications
for the Sendai Framework. Progress in Disaster
Science, 6, 100080.
https://doi.org/10.1016/j.pdisas.2020.100080
[3] Donthu, N., & Gustafsson, A. (2020). Effects of
COVID-19 on business and research. Journal of
Business Research, 117, 284–289.
https://doi.org/10.1016/j.jbusres.2020.06.008
[4] El Baz, J., & Ruel, S. (2021). Can supply chain
risk management practices mitigate the
disruption impacts on supply chains’ resilience
and robustness? Evidence from an empirical
survey in a COVID-19 outbreak era.
International Journal of Production Economics,
233, 107972.
https://doi.org/10.1016/j.ijpe.2020.107972
[5] Huremović, D. (2019). Brief History of
Pandemics (Pandemics Throughout History). In
Psychiatry of Pandemics (pp. 7–35). Springer
International Publishing.
https://doi.org/10.1007/978-3-030-15346-5_2
[6] Ioannidis, J. P. A. (2021). Infection fatality rate
of COVID-19 inferred from seroprevalence
data. Bulletin of the World Health Organization,
99(1), 19-33F.
https://doi.org/10.2471/BLT.20.265892
[7] Jamaludin, S., Azmir, N. A., Mohamad Ayob,
A. F., & Zainal, N. (2020). COVID-19 exit
strategy: Transitioning towards a new normal.
Annals of Medicine and Surgery, 59, 165–170.
https://doi.org/10.1016/j.amsu.2020.09.046
[8] Jebril, N. (2020). World Health Organization
Declared a Pandemic Public Health Menace: A
Systematic Review of the Coronavirus Disease
2019 “COVID-19.” SSRN Electronic Journal.
https://doi.org/10.2139/ssrn.3566298
[9] Karmaker, C. L., Ahmed, T., Ahmed, S., Ali, S.
M., Moktadir, M. A., & Kabir, G. (2021).
Improving supply chain sustainability in the
context of COVID-19 pandemic in an emerging
economy: Exploring drivers using an integrated
model. Sustainable Production and
Consumption, 26, 411–427.
https://doi.org/10.1016/j.spc.2020.09.019
[10] Larsen, J. R., Martin, M. R., Martin, J. D., Kuhn,
P., & Hicks, J. B. (2020). Modeling the Onset of
Symptoms of COVID-19. Frontiers in Public
Health, 8.
https://doi.org/10.3389/fpubh.2020.00473
[11] Leite, H., Hodgkinson, I. R., & Gruber, T.
(2020). New development: ‘Healing at a
distance’—telemedicine and COVID-19. Public
Money & Management, 40(6), 483–485.
https://doi.org/10.1080/09540962.2020.174885
5
[12] Malecki, F. (2020). Overcoming the security
risks of remote working. Computer Fraud &
Security, 2020(7), 10–12.
https://doi.org/10.1016/S1361-3723(20)30074-
9
[13] Nakat, Z., & Bou-Mitri, C. (2021). COVID-19
and the food industry: Readiness assessment.
Food Control, 121, 107661.
https://doi.org/10.1016/j.foodcont.2020.107661
[14] O’Neill, R. (2020). WHO Knew. How the
World Health Organization (WHO) Became a
Dangerous Interloper on Workplace Health and
Safety and COVID-19. NEW SOLUTIONS: A
WSEAS TRANSACTIONS on ENVIRONMENT and DEVELOPMENT
DOI: 10.37394/232015.2022.18.60
G. Chatzistelios, E. P. Kechagias,
S. P. Gayialis, G. A. Papadopoulos,
N. E. Spyridonakos